François et al. used targeted next-generation sequencing to prospectively sequence tumors and found a significant correlation between the risk of bladder recurrence after radical surgery for UTUC and mutations in FGFR3, KDM6A, CCND1, and TP53 [34]. This evidence concerns the gene TP53 and renal pelvis/ureter urothelial carcinoma.